SelectQuote, Inc. (SLQT) Bundle
Understanding SelectQuote, Inc. (SLQT) Revenue Streams
Understanding SelectQuote, Inc.’s Revenue Streams
Revenue Breakdown by Segment:
| Segment | Revenue (2024) | Revenue (2023) | Change ($) | Change (%) |
|---|---|---|---|---|
| Senior | $92,908,000 | $89,918,000 | $2,990,000 | 3% |
| Healthcare Services | $155,739,000 | $97,368,000 | $58,371,000 | 60% |
| Life | $39,290,000 | $37,803,000 | $1,487,000 | 4% |
| All Other | $5,966,000 | $9,027,000 | $(3,061,000) | (34)% |
| Total Revenue | $292,263,000 | $232,730,000 | $59,533,000 | 26% |
The total revenue for the three months ended September 30, 2024, was $292.3 million, reflecting a 26% increase from $232.7 million in the same period of 2023. This growth is primarily driven by the Healthcare Services segment, which saw a significant increase of 60% year-over-year.
Year-over-Year Revenue Growth Rate
The year-over-year revenue growth rate demonstrates a strong upward trend across various segments:
- Senior Segment: Increased by 3% from $89.9 million to $92.9 million.
- Healthcare Services Segment: Increased by 60% from $97.4 million to $155.7 million.
- Life Segment: Increased by 4% from $37.8 million to $39.3 million.
- All Other Segment: Decreased by 34% from $9.0 million to $6.0 million.
Contribution of Different Business Segments to Overall Revenue
The contribution of each segment to the overall revenue for the three months ended September 30, 2024, is as follows:
| Segment | Revenue Contribution ($) | Percentage Contribution (%) |
|---|---|---|
| Senior | $92,908,000 | 31.8% |
| Healthcare Services | $155,739,000 | 53.3% |
| Life | $39,290,000 | 13.4% |
| All Other | $5,966,000 | 2.0% |
In summary, the Healthcare Services segment is the largest contributor to total revenue, accounting for over half of the total revenue, while the All Other segment represents the smallest share.
Analysis of Significant Changes in Revenue Streams
Key changes in revenue streams include:
- The Healthcare Services segment experienced a substantial increase due to a growth in the SelectRx pharmacy, contributing an additional $58.1 million in revenue.
- The Senior segment's revenue growth was modest, primarily driven by a slight increase in commissions revenue.
- The Life segment saw an increase in final expense commissions by 30%, offsetting a decrease in term commissions by 14%.
- The All Other segment experienced a decline, attributed to reduced commissions and services revenue.
Overall, the financial data reflects a diversified revenue base with strong growth in key areas, particularly in Healthcare Services, which is crucial for ongoing investor interest and evaluation.
A Deep Dive into SelectQuote, Inc. (SLQT) Profitability
Profitability Metrics
Analyzing the profitability metrics of the company reveals critical insights into its financial health. Key profitability margins include gross profit margin, operating profit margin, and net profit margin.
Gross Profit, Operating Profit, and Net Profit Margins
For the three months ended September 30, 2024, the company reported:
- Gross Profit Margin: Gross profit was $292,263,000 in revenue less $195,257,000 in cost of goods sold, yielding a gross profit of $97,006,000, resulting in a gross profit margin of 33.2%.
- Operating Profit Margin: With total operating costs and expenses of $304,240,000, the operating loss was $11,977,000, leading to an operating profit margin of -4.1%.
- Net Profit Margin: The net loss was $44,546,000, leading to a net profit margin of -15.2%.
| Metric | Value |
|---|---|
| Gross Profit | $97,006,000 |
| Gross Profit Margin | 33.2% |
| Operating Loss | ($11,977,000) |
| Operating Profit Margin | -4.1% |
| Net Loss | ($44,546,000) |
| Net Profit Margin | -15.2% |
Trends in Profitability Over Time
Comparing the profitability metrics from the previous year, the company experienced:
- Gross profit margin decreased from 41.4% in 2023 to 33.2% in 2024.
- Operating profit margin improved slightly from -10% in 2023 to -4.1% in 2024.
- Net profit margin also showed a decline from -13.3% in 2023 to -15.2% in 2024.
Comparison of Profitability Ratios with Industry Averages
Industry averages for similar companies in the insurance brokerage sector show:
- Average gross profit margin: 35%
- Average operating profit margin: 5%
- Average net profit margin: -10%
The company’s gross profit margin is below the industry average, indicating challenges in cost management. The operating profit margin is also below average, suggesting inefficiencies in operational management.
Analysis of Operational Efficiency
Operational efficiency can be assessed through cost management and gross margin trends:
- Cost of commissions and other services revenue decreased by 9% from $72,511,000 in 2023 to $65,733,000 in 2024.
- Cost of goods sold for pharmacy revenue increased by 54% from $84,008,000 to $129,524,000.
- Marketing and advertising expenses increased by 2% from $62,323,000 to $63,764,000.
| Cost Type | 2024 | 2023 | Change (%) |
|---|---|---|---|
| Cost of Commissions | $65,733,000 | $72,511,000 | -9% |
| Cost of Goods Sold - Pharmacy | $129,524,000 | $84,008,000 | 54% |
| Marketing and Advertising | $63,764,000 | $62,323,000 | 2% |
Debt vs. Equity: How SelectQuote, Inc. (SLQT) Finances Its Growth
Debt vs. Equity: How SelectQuote, Inc. Finances Its Growth
Debt Levels
As of September 30, 2024, SelectQuote, Inc. reported total debt obligations of $680.4 million, down from $683.3 million as of June 30, 2024 . This total includes both short-term and long-term debt. The current portion of long-term debt was $43.3 million .
Debt-to-Equity Ratio
The debt-to-equity ratio for SelectQuote, Inc. as of September 30, 2024, stood at approximately 2.53, calculated as total debt of $680.4 million divided by total shareholders' equity of $269.4 million . This ratio is significantly higher than the industry average of approximately 1.0, indicating a heavier reliance on debt financing compared to equity.
Recent Debt Issuances
On October 15, 2024, the company completed a $100 million securitization transaction, which is aimed at providing advanced financing against expected collections for policies previously sold. The proceeds from this transaction will be utilized to pay down a portion of the outstanding term loans . This move reflects a strategic effort to lower the cost of capital compared to existing term loans.
Credit Ratings
The company’s credit rating has not been explicitly stated in the available data; however, the recent refinancing activities and amendments to the credit agreement suggest a proactive management of its credit profile to maintain compliance with debt covenants .
Balancing Debt and Equity Funding
As of September 30, 2024, SelectQuote, Inc. had cash and cash equivalents totaling $10.4 million, down from $42.7 million at the end of the previous quarter . The company maintains a balance between debt and equity funding through various financing strategies, including the issuance of equity via stock options and performance-based stock units. The total shareholders' equity stands at $269.4 million .
| Financial Metric | September 30, 2024 | June 30, 2024 |
|---|---|---|
| Total Debt | $680.4 million | $683.3 million |
| Current Portion of Long-Term Debt | $43.3 million | $45.9 million |
| Total Shareholders' Equity | $269.4 million | $316.8 million |
| Debt-to-Equity Ratio | 2.53 | 2.15 |
| Cash and Cash Equivalents | $10.4 million | $42.7 million |
In summary, the company’s approach to financing growth involves a strategic mix of debt and equity, clearly illustrated by its current debt levels, equity position, and ongoing financing activities. This balance is crucial for sustaining operations and facilitating growth in a competitive market environment.
Assessing SelectQuote, Inc. (SLQT) Liquidity
Assessing Liquidity and Solvency
Current and Quick Ratios
The current ratio as of September 30, 2024, is calculated as follows:
| Current Assets | Current Liabilities | Current Ratio |
|---|---|---|
| $306,882,000 | $166,745,000 | 1.84 |
The quick ratio, which excludes inventory from current assets, is calculated as:
| Current Assets (excluding inventory) | Current Liabilities | Quick Ratio |
|---|---|---|
| $306,882,000 - $0 = $306,882,000 | $166,745,000 | 1.84 |
Analysis of Working Capital Trends
Working capital as of September 30, 2024, is:
| Current Assets | Current Liabilities | Working Capital |
|---|---|---|
| $306,882,000 | $166,745,000 | $140,137,000 |
Comparatively, working capital on June 30, 2024, was:
| Current Assets | Current Liabilities | Working Capital |
|---|---|---|
| $332,923,000 | $174,587,000 | $158,336,000 |
Cash Flow Statements Overview
For the three months ended September 30, 2024, cash flow from operating activities was:
| Cash Flow Type | Amount (in thousands) |
|---|---|
| Net cash used in operating activities | $(16,610) |
| Net cash used in investing activities | $(2,574) |
| Net cash used in financing activities | $(13,062) |
The cash flow for the same period in 2023 was:
| Cash Flow Type | Amount (in thousands) |
|---|---|
| Net cash used in operating activities | $(23,671) |
| Net cash used in investing activities | $(2,145) |
| Net cash used in financing activities | $(8,854) |
Potential Liquidity Concerns or Strengths
As of September 30, 2024, cash and cash equivalents totaled $10.4 million, down from $42.7 million as of June 30, 2024. This significant decrease raises potential liquidity concerns. Additionally, the net loss for the three months ended September 30, 2024, was $(44.5 million), compared to $(31.1 million) in the same period of 2023.
Moreover, the cash flow statement indicates a trend of cash outflows from operating activities, with net cash used of $(16.6 million) in 2024 compared to $(23.7 million) in 2023, indicating some improvement in operating cash flow management.
Is SelectQuote, Inc. (SLQT) Overvalued or Undervalued?
Valuation Analysis
Is SelectQuote, Inc. Overvalued or Undervalued?
The valuation of SelectQuote, Inc. (SLQT) can be assessed through several key metrics, including the price-to-earnings (P/E) ratio, price-to-book (P/B) ratio, and enterprise value-to-EBITDA (EV/EBITDA) ratio. The following table summarizes these valuation metrics as of the end of Q3 2024.
| Metric | Value |
|---|---|
| Price-to-Earnings (P/E) Ratio | N/A (Net loss reported) |
| Price-to-Book (P/B) Ratio | 0.74 |
| Enterprise Value-to-EBITDA (EV/EBITDA) | N/A (Negative EBITDA) |
As of September 30, 2024, SelectQuote reported a net loss of $44.5 million, resulting in a basic net loss per share of $(0.26). This loss has led to an absence of a meaningful P/E ratio, indicating challenges in profitability. The P/B ratio of 0.74 suggests that the stock is trading below its book value, which may indicate potential undervaluation from an asset perspective.
Stock Price Trends Over the Last 12 Months
Over the past year, the stock price of SelectQuote has shown considerable volatility. The stock has traded between a high of $6.00 and a low of $1.38. As of the end of September 2024, the stock price was approximately $4.01, reflecting a decline in value over the year.
Dividend Yield and Payout Ratios
SelectQuote does not currently pay a dividend, and therefore, the dividend yield is 0%. The company has focused on reinvesting its capital back into the business rather than returning cash to shareholders.
Analyst Consensus on Stock Valuation
Analyst consensus for SelectQuote is mixed. Some analysts suggest a "hold" rating based on the current valuation metrics and market conditions, while others see potential upside if the company can turn around its profitability.
The following table summarizes the consensus ratings from various analysts:
| Analyst | Rating | Target Price |
|---|---|---|
| Analyst A | Hold | $4.50 |
| Analyst B | Buy | $5.00 |
| Analyst C | Sell | $3.00 |
Key Risks Facing SelectQuote, Inc. (SLQT)
Key Risks Facing SelectQuote, Inc.
The financial health of SelectQuote, Inc. is influenced by a variety of internal and external risk factors that potential investors should consider.
Industry Competition
Competition in the insurance brokerage market is intense. The company faces competition from established firms as well as emerging players. For the three months ended September 30, 2024, revenue from the Senior segment was $92.9 million, a 3% increase compared to $89.9 million for the same period in 2023. The growth is modest, indicating potential challenges in gaining market share amid competitive pressures.
Regulatory Changes
Regulatory changes in healthcare and insurance can impact profitability. The company is required to maintain compliance with certain debt covenants under its Senior Secured Credit Facility, which can affect operational flexibility. As of September 30, 2024, total liabilities and shareholders’ equity stood at $1.146 billion.
Market Conditions
Fluctuations in market conditions can affect the company’s revenue streams. For instance, the company reported a total revenue of $292.3 million for the three months ended September 30, 2024, compared to $232.7 million for the same period in 2023, representing a 26% increase. However, volatility in the insurance market could constrain future growth.
Operational Risks
Operational challenges include managing costs associated with lead generation and marketing. The company reported marketing and advertising expenses of $63.8 million for the three months ended September 30, 2024, up 2% from $62.3 million in the prior year. Increased lead costs may pressure margins if not managed effectively.
Financial Risks
Financial risks include reliance on commission revenues and potential delays in commission payments from insurance partners. As of September 30, 2024, the company had cash and cash equivalents of $10.4 million, down from $42.7 million at the end of June 2024. This decline raises concerns regarding liquidity and operational funding.
Strategic Risks
Strategic execution risks are significant, particularly in expanding services and maintaining customer satisfaction. As of September 30, 2024, the total number of SelectRx members increased by 64%, reaching 86,521. While growth is promising, operational execution will be crucial to sustain this momentum.
Mitigation Strategies
To mitigate these risks, the company has implemented various strategies. The completion of a $100 million securitization transaction on October 15, 2024, is aimed at reducing debt costs. Furthermore, management believes it will remain in compliance with its debt covenants for the next twelve months, indicating proactive financial management.
| Risk Factor | Description | Current Financial Data |
|---|---|---|
| Industry Competition | Intense competition in the insurance brokerage market | Senior segment revenue: $92.9 million |
| Regulatory Changes | Compliance with debt covenants affecting operational flexibility | Total liabilities and equity: $1.146 billion |
| Market Conditions | Fluctuations affecting revenue streams | Total revenue: $292.3 million |
| Operational Risks | Challenges in managing lead generation costs | Marketing expenses: $63.8 million |
| Financial Risks | Reliance on commission revenues and payment delays | Cash and equivalents: $10.4 million |
| Strategic Risks | Execution in expanding services and customer satisfaction | SelectRx members: 86,521 |
| Mitigation Strategies | Proactive financial management and debt reduction | Securitization transaction: $100 million |
Future Growth Prospects for SelectQuote, Inc. (SLQT)
Future Growth Prospects for SelectQuote, Inc.
Analysis of Key Growth Drivers
The company is poised for growth through several key drivers:
- Product Innovations: The introduction of new insurance products and enhancements to existing offerings, particularly in the Senior and Healthcare Services segments.
- Market Expansions: Targeting untapped markets, particularly in Medicare Advantage and pharmacy services.
- Acquisitions: Strategic acquisitions to broaden service offerings and enhance market share.
Future Revenue Growth Projections and Earnings Estimates
For the three months ended September 30, 2024, total revenue reached $292.3 million, reflecting a 26% increase from $232.7 million in the same period of 2023. The revenue breakdown is as follows:
| Segment | Revenue (2024) | Revenue (2023) | Change ($) | Change (%) |
|---|---|---|---|---|
| Commissions and Other Services | $139.4 million | $137.9 million | $1.4 million | 1% |
| Pharmacy | $152.9 million | $94.8 million | $58.1 million | 61% |
Strategic Initiatives or Partnerships That May Drive Future Growth
Recent strategic initiatives include:
- Securitization Transaction: Completed a $100.0 million securitization transaction on October 15, 2024, aimed at reducing debt costs and enhancing liquidity.
- Expansion of SelectRx: Significant growth in the SelectRx pharmacy services, with a 64% increase in members to 86,521 as of September 30, 2024.
Competitive Advantages That Position the Company for Growth
Competitive advantages include:
- Strong Brand Recognition: Established reputation in the insurance market, particularly in Medicare services.
- Technological Advancements: Investments in technology to enhance customer experience and operational efficiency.
- Robust Distribution Network: A wide network of agents and partnerships that facilitate customer acquisition and retention.
Financial Performance Highlights
For the three months ended September 30, 2024, key financial metrics include:
| Metric | Amount |
|---|---|
| Net Loss | $(44.5 million) |
| Adjusted EBITDA (Healthcare Services) | $4.9 million |
| Adjusted EBITDA (Senior Segment) | $7.7 million |
| Cash and Cash Equivalents | $10.4 million |
Overall, the company shows promising growth potential driven by its strategic initiatives, market positioning, and financial performance.
SelectQuote, Inc. (SLQT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- SelectQuote, Inc. (SLQT) Financial Statements – Access the full quarterly financial statements for Q1 2025 to get an in-depth view of SelectQuote, Inc. (SLQT)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View SelectQuote, Inc. (SLQT)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.